RE:GeneNews and NueHealth Announce Partnership in Early Cancer The partnership has an initial term of three years and is renewable annually thereafter. GeneNews will provide individualized risk stratification reports for each patient, the supply of testing kits and ongoing consultation. The diagnostic services are provided via a flat-fee model, with NueHealth responsible for the management of client billing within its value-based healthcare solution model. While financial terms were not disclosed, GeneNews noted that it expects this partnership to significantly accelerate the path toward positive cash-flow and net profitability